Volume 2, Issue 3 (Spring- In Press 2024) CPR 2024, 2(3): 0-0 | Back to browse issues page

‎ 10.32598/cpr.2.3.222.1

Ethics code: N/A

Clinical trials code: N/A

Mendeley

Zotero

RefWorks

Rafaiee R, Ghazvini H, Hosseini S H. Fibromyalgia Through the Lens of COVID-19: New Research Opportunities. CPR 2024; 2 (3)
URL: http://cpr.mazums.ac.ir/article-1-120-en.html

Fibromyalgia Through the Lens of COVID-19: New Research Opportunities

Raheleh Rafaiee

, Hamed Ghazvini

, Seyeh Hamzeh Hosseini

Department of Psychiatry, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Abstract: (183 Views)

Fibromyalgia (FM), a complex chronic pain syndrome affecting 5% of the global population, has a multifactorial etiology involving genetic, neuroendocrine, and environmental factors. The COVID-19 pandemic has brought new insights into FM, with emerging evidence showing that COVID-19 survivors may develop FM-like symptoms. It raises the possibility of an overlap with post-viral syndromes. Studies indicate that nearly one-third of post-COVID patients meet FM criteria, with factors like obesity and male gender influencing susceptibility. Additionally, the heightened anxiety associated with COVID-19 exacerbates FM symptoms, suggesting the role of psychological stress. Recognizing FM in the context of long-term COVID-19 can enlighten treatment strategies, particularly with insights from rheumatology, which may enhance disease outcomes. This research intersection underscores an urgent need for comprehensive studies to clarify the impact of viral infections on chronic pain syndromes, potentially refining the management and classification of FM.

Keywords: Fibromyalgia, COVID-19, Editorial

Type of Study: Letter to Editor | Subject: Health
Received: 2024/10/2 | Accepted: 2024/04/1 | Published: 2024/04/1

Send email to the article author

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.